In recent years, a type II transmembrane serine protease called hepsin has attracted attention due to its overexpression and oncogenic functions in prostate cancer [11,12,13,14,15,16,17,18,19,20,21,22]. The gene discussed is HPN; the disease is prostate carcinoma.